What are U.S. companies doing with cash?

The Russell 1000 aggregate cash pile reached $2.2 trillion while cash-to-EV slid to a 20-year low of 3.8%, as firms aggressively redeploy capital. Capex jumped 21.2% YoY to $1.2 trillion and FCF remains around $1.6 trillion with an FCF yield floor of 2.8%; consensus expects net margins to expand to ~15.3% over the next 12 months. Morgan Stanley highlights cash-rich large caps (ServiceNow, Vertex, CrowdStrike) as better positioned, but warns that a sustained Middle East energy shock and a higher-for-longer inflation backdrop could test corporate cash defenses.

Analysis

Managements are front-loading capital projects in an environment where execution risk and energy-cost sensitivity have risen; that front-loading amplifies exposure to two levers — demand realization and input-price volatility — so the path to realized returns is longer and bumpier than headline capex numbers imply. Expect the next two earnings cycles to bifurcate winners: firms with durable recurring revenue and high incremental margins will convert recent spend into visible margin improvement, while those reliant on cyclical hardware or one-time supply chains will show elongated payback periods.

A less-obvious beneficiary of this cycle is the specialist supplier and software partner that embeds long-term contracts into customer capex (managed services, security, orchestration), since their revenues reprice less with spot energy swings and preserve FCF conversion. Conversely, capital equipment vendors and high-growth names that must access external funding are second-order losers if risk premia tick up; funding squeezes will compress multiples faster than top-line deceleration.

Key catalysts to watch are directional moves in energy risk and credit spreads: short-duration shocks (days–weeks) from geopolitical flare-ups will create tactical volatility, while sustained stress in funding markets (months) will force visible capex slowdowns and margin downgrades. Monitor supplier order books, backlog cancellations, and corporate guidance cadence — those metrics will lead reported margin improvement by two to three quarters.

Contrarian point: the market is over-indexing to the durability of margin expansion — much of the recent spend is scale-oriented and will increase depreciation and fixed cost absorption before driving incremental FCF. If interest rates reprice or an energy shock persists, the “growth at the margin” narrative will reverse quickly; the prudent stance is active selection, not blanket exposure to capex beneficiaries.

Key Decisions for Investors

• Long VRTX — Initiate a 1–2% NAV position with a 12-month horizon; target +30–40% total return if pipeline/M&A optionality re-rates the equity, hard stop at -15% to limit binary clinical risk.
• Pair trade: Long CRWD / Short SMCI — 6–9 month trade sized to be dollar-neutral (e.g., 1% NAV long CRWD vs 1% NAV short SMCI). Rationale: SaaS security cash conversion vs hardware cyclical and inventory risk; target 20–30% spread tightening in favor of CRWD, stop-loss if spread moves 10% against position.
• Options tactical: Buy a 9–12 month call spread on NET (debit-funded by selling an OTM call) sized at 0.5–1% NAV. Objective is ~2x payout if security/edge spend stays resilient; max loss limited to premium paid, take profits early on a 50–60% move.
• Portfolio defense: Trim small-cap, low-FCF growth names (e.g., APP-sized positions) by 25–50% and redeploy into high-quality, high-FCF names (NOW, VRTX, CRWD) over the next 30–90 days to reduce funding and energy exposure while preserving upside.